By Finance Pulse in Stock Market —

Neumora's Depression Drug Trial Fails, Shares Plunge 82%

Neumora Therapeutics' depression drug falls short in final-stage trial, leading to an 82% pre-market share drop. Discover the impact on Neumora's future prospects.

A dramatic depiction of a stock chart plummeting against a background of somber blue tones, capturin
Neumora's Depression Drug Trial Fails, Shares Plunge 82%

Neumora's depression drug fails final-stage trial causing an 82% pre-market share drop.

Source